Plasma membrane transporters belonging to the family of Na ϩ /Cl Ϫ -dependent neurotransmitter transporters play an important role in terminating the activity of the monoamine neurotransmitters and of ␥-aminobutyric acid (see Ref. 1). Thus, reuptake of dopamine (DA) 1 from the synaptic cleft by the dopamine transporter (DAT) serves as the major mechanism for terminating dopaminergic neurotransmission in the brain (2). Because the efficiency of DA removal depends on the number of DAT molecules expressed at the plasma membrane, trafficking processes that control transporter distribution in the cell represent a potentially important mechanism by which neurotransmission could be regulated. Newly synthesized DAT acquires glycosylation in the endoplasmic reticulum (ER) and Golgi complex and is then trafficked to the plasma membrane. Typically, a large pool of mature DAT molecules are found at the cell surface of dopaminergic neurons and when DAT is heterologously expressed in tissue culture cells. However, DAT localization can be altered rapidly. Acute exposure of cells to either phorbol esters or substrates reduces the number of plasma membrane DATs and thus DAT function, and this reduction is due to acceleration of DAT endocytosis through a dynamin-dependent mechanism (3-6). Recently, it has been shown that DAT can interact with the anchoring protein PICK 1 and the adaptor protein 8) . However, in general, the molecular mechanisms controlling DAT trafficking are not yet well understood.
Plasma membrane transporters belonging to the family of Na ϩ /Cl Ϫ -dependent neurotransmitter transporters play an important role in terminating the activity of the monoamine neurotransmitters and of ␥-aminobutyric acid (see Ref. 1) . Thus, reuptake of dopamine (DA) 1 from the synaptic cleft by the dopamine transporter (DAT) serves as the major mechanism for terminating dopaminergic neurotransmission in the brain (2) . Because the efficiency of DA removal depends on the number of DAT molecules expressed at the plasma membrane, trafficking processes that control transporter distribution in the cell represent a potentially important mechanism by which neurotransmission could be regulated. Newly synthesized DAT acquires glycosylation in the endoplasmic reticulum (ER) and Golgi complex and is then trafficked to the plasma membrane. Typically, a large pool of mature DAT molecules are found at the cell surface of dopaminergic neurons and when DAT is heterologously expressed in tissue culture cells. However, DAT localization can be altered rapidly. Acute exposure of cells to either phorbol esters or substrates reduces the number of plasma membrane DATs and thus DAT function, and this reduction is due to acceleration of DAT endocytosis through a dynamin-dependent mechanism (3) (4) (5) (6) . Recently, it has been shown that DAT can interact with the anchoring protein PICK 1 and the adaptor protein Hic-5 (7, 8) . However, in general, the molecular mechanisms controlling DAT trafficking are not yet well understood.
The DAT molecule is predicted to have 12 membrane-spanning sequences with both amino and carboxyl termini oriented intracellularly. The specific function of DAT transmembrane (TM) motifs and termini are not well established. TM domains may play a role in intra-and intermolecular interactions. Many membrane receptors and other integral membrane proteins require dimerization or higher oligomerization for their activity. Several lines of evidence have suggested that monoamine transporters are also dimers or oligomers. Results with dominant negative forms of the serotonin transporter (SERT) and norepinephrine transporter were consistent with this idea (9, 10) . Oligomerization of SERT was demonstrated directly by co-immunoprecipitation (11) . The results of fluorescence resonance energy transfer (FRET) studies further confirmed that SERT and a ␥-aminobutyric acid transporter (GAT-1) are homo-oligomers (12, 13) . Early radiation inactivation studies also suggested that DAT exists as a dimer or oligomer (14, 15) . Recently, the potential for DAT to exist as dimer or higherorder oligomer in the plasma membrane has been demonstrated using chemical cross-linking (16) . More recently, Torres and co-workers (17) reported detection of DAT oligomerization by co-immunoprecipitation. In general, the mechanisms and functional roles of oligomerization of monoamine transporters remain to be defined. However, it has been proposed that SERT oligomerization may be important for its transport activity (9) . Oligomerization may be also required for proper trafficking of the newly synthesized transporter to the plasma membrane (13, 17) .
Hence, we generated fluorescent human DAT fusion proteins, which allow visualization of DAT interactions during trafficking in living cells, and then used these proteins in conjunction with high resolution FRET microscopy to examine DAT oligomerization in various cellular compartments. The effective energy transfer between cyan (CFP) and yellow fluorescent protein (YFP) occurs when two proteins are 1-5 nM apart. This close proximity typically requires direct interaction of proteins tagged with YFP and CFP. Measurements of sensitized FRET signals (fluorescence of the acceptor due to energy transfer from excited donor) on a pixel-by-pixel basis are designed to visualize protein-protein interactions in individual compartments of single living cells. Using this approach, we found that DAT is oligomerized in all cellular compartments in which it is localized, including post-synthetic compartments, plasma membrane, and endosomes, where DAT is accumulated when endocytosis is stimulated by phorbol esters or the DAT substrate amphetamine. Plasmids-To generate the fusion proteins of human DAT (18) with YFP (YFP-DAT) or CFP (CFP-DAT), a DNA fragment encoding the full-length DAT was obtained by PCR using Pfu polymerase (Stratagene Cloning Systems, La Jolla, CA), with a KpnI restriction site introduced into the 5Ј-end and a SmaI site into the 3Ј-end, and cloned into the pEYFP-C1 vector or pECFP-C1 vector (Clontech, Palo Alto, CA), respectively. To generate YFP-DATЈC615, a stop codon was created at the position corresponding to amino acid residue 616 in the full-length DAT/pEYFP-C1 using a QuikChange site-directed mutagenesis kit according to the manufacture's protocol (Stratagene). To generate YFP-⌬N-DAT lacking amino-terminal cytoplasmic portion, a DNA fragment encoding the DAT sequence corresponding to amino acid residues 66 -620 was obtained by PCR using Pfu polymerase with a KpnI restriction site introduced into the 5Ј-end and a SmaI site into the 3Ј-end, and cloned into the pEYFP-C1 vector.
EXPERIMENTAL PROCEDURES

Chemicals and Antibodies-Phorbol
Human Rab5a and Rab11a cDNAs were obtained from Guthrie cDNA Resource Center (Guthrie Research Institute, Sayre, PA). To generate YFP fusion proteins, full-length Rab5a and Rab11a were amplified by PCR and ligated into pEYFP-C1 by using the BglII and XhoI restriction sites. All constructs were verified by dideoxynucleotide sequencing. The construct EGFR-CFP was previously described (19) . YFP-Hrs (hepatocyte-growth factor receptor substrate) was provided by Dr. H. Stenmark (Radium Institute, Oslo, Norway).
Cell Culture and Transfections-Porcine aortic endothelial (PAE) cells were grown in F12 medium containing 10% fetal bovine serum, antibiotics, and glutamine. HEK293T cells (further referred to as HEK293) were grown in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, antibiotics, and glutamine. Cells were grown to 50 -80% confluency and transfected with appropriate plasmids using Effectine (Qiagen, Hilden, Germany). In transient transfection experiments, the cells were split 1 day after transfection onto glass coverslips and used for experiments on the second or third day at about 50% confluency. For biochemical immunoprecipitation and biotinylation experiments the cells were plated into 100-or 35-mm dishes, respectively, and used for experiments on the second day at about 90% confluency. Entactin-Collagen IV-Laminin coating (Upstate Biotechnology, Lake Placid, NY) was applied to 35-mm dishes to increase HEK293 cell adherence. The immortalized dopaminergic cell line 1RB 3 AN 27 was kindly provided by Dr. K. Prasad (University of Colorado Health Sciences Center) (20) . These cells were grown in RPMI medium supplemented with 10% fetal bovine serum and antibiotics.
For selection of stable clones, PAE cells transfected with CFP-DAT, YFP-DAT, DAT, or YFP-⌬N-DAT were grown with G418 (400 g/ml) to obtain a pool of constitutively expressing cells. The single cell clone selection was then carried out by the limited dilution method in 96-well dishes. PAE cells stably expressing DAT were transfected with a mixture of YFP-⌬N-DAT and pSUMS-Hygro constructs (10:1) and grown with G418 and hygromycin (0.2 g/ml) to obtain clones stably expressing both DAT and YFP-⌬N-DAT.
Uptake Assays-PAE cells expressing hDAT, CFP-DAT, or YFP-DAT were grown in 12-well plates for 2-3 days. The cells were rinsed and then assayed in Krebs-Ringer HEPES buffer (KRH; 120 mM NaCl, 4.7 mM KCl, 2.2. mM CaCl 2 , 1.2 mM Mg SO 4 , 1.2 mM KH 2 PO 4 , 10 mM glucose, 10 mM HEPES, pH 7.4) supplemented with 10 M pargyline, 10 M ascorbic acid, and 10 M catechol. Assays (1 ml) included 50 nM [ 3 H]DA plus increasing amounts of unlabeled DA (final concentrations 50 nM to 50 M). Nonspecific [ 3 H]DA accumulation was determined in the presence of 1 mM cocaine and averaged 2.0 Ϯ 0.2% of total. After 10 min of incubation at 37°C, uptake was terminated by quickly washing the cells three times with 1 ml of ice-cold KRH. Cells were then solubilized in 0.5 ml of 3% trichloroacetic acid for 30 min with gently shaking. Accumulated [ 3 H]DA was determined by liquid scintillation counting. Data were analyzed using GraphPad Prism (San Diego, CA).
Immunoprecipitation-PAE cells stably expressing DAT and/or YFP-⌬N-DAT grown on 100-mm dishes to about 90% confluency were washed three times with Ca 2ϩ ,Mg 2ϩ -free phosphate-buffered saline (CMF-PBS). The cells were then solubilized by scraping with a rubber policeman in lysis buffer (50 mM NaCl, 2 mM MgCl 2 , 20 mM HEPES, pH 7.2, 10% glycerol, 10 mM dithiothreitol (DTT), 1 mM EGTA, 1 mM EDTA, 10 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 544 M iodoacetamide, 10 g/ml aprotinin, 1% Triton X-100, 1% sodium deoxycholate) and by further incubating for 10 min at 4°C. The lysates were then cleared by centrifugation for 10 min at 16,000 ϫ g and incubated with polyclonal antibodies to GFP (18 g per dish) overnight at 4°C. Under these conditions, at least 95% of YFP-⌬N-DAT was immunoprecipitated. The precipitates were washed twice with lysis buffer supplemented with 100 mM NaCl, washed once without NaCl, and then denatured by heating in sample buffer for 5 min at 95°C. The immunoprecipitates and the aliquots of cell lysates were resolved on 7.5% SDS-PAGE, and the proteins were transferred to the membrane. Western blotting was performed with monoclonal antibodies to GFP or DAT followed by species-specific secondary antibodies conjugated with horseradish peroxidase. The enhanced chemiluminescence kit was purchased from Pierce (Rockford, IL).
Surface Biotinylation-PAE or HEK293T cells were grown in 35-mm dishes and used at 100% confluency. Cells were washed twice with cold phosphate-buffered saline containing 0.1 mM CaCl 2 and 1 mM MgCl 2 (PBS) and incubated for 20 min on ice with 1 mg/ml sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate (EZ-Link TM sulfo-NHS-S-Sbiotin, Pierce) in PBS, followed by a second incubation with fresh NHS-S-S-biotin. After biotinylation, the cells were washed twice with cold PBS, incubated 20 min on ice with 0.1 M glycine in PBS, washed with PBS again, and solubilized in lysis buffer (see above) supplemented with 10 mM Tris-HCl (pH 6.8) in which DTT was omitted. Cell lysates were precleared by centrifugation at 16,000 ϫ g; the biotinylated proteins were precipitated with NeutrAvidin TM beads (Pierce), washed five times with lysis buffer, incubated in sample buffer supplemented with 100 mM DTT for 10 min to cleave disulfide bonds, and denatured by heating the beads in sample buffer at 95°C for 5 min. Supernatants from the NeutrAvidin precipitation and the aliquots of cell lysates were further subjected to immunoprecipitation with rat anti-DAT or polyclonal anti-GFP. NeutrAvidin beads and immunoprecipitates were analyzed by electrophoresis and Western blotting.
Immunofluorescence Staining-PAE cells expressing CFP-DAT were grown on glass coverslips and treated with Me 2 SO, PMA, or amphetamine at 37°C. The cells were then washed with CMF-PBS and fixed with freshly prepared 4% paraformaldehyde (Electron Microscopy Sciences, Ft. Washington, PA) for 15 min at room temperature and mildly permeabilized using a 3-min incubation in CMF-PBS containing 0.1% Triton X-100 and 0.5% bovine serum albumin at room temperature. Cells were then incubated in CMF-PBS containing 0.5% bovine serum albumin at room temperature for 1 h with a monoclonal antibody to ⌭⌭〈.1 and then incubated for 30 min with a secondary donkey antimouse IgG labeled with Cy3 (Jackson Laboratories, West-Glove, PA). Both primary and secondary antibody solutions were precleared by centrifugation at 100,000 ϫ g for 10 min. After staining, the coverslips were mounted in Fluoromount-G (Southern Biotech Inc., Birmingham, AL) containing 1 mg/ml para-phenylenediamine. To obtain high resolution three-dimensional images of cells, the fluorescence imaging workstation consisted of a Nikon inverted microscope equipped with a 100ϫ oil immersion objective lens, cooled charge-coupled device SensiCam QE 16 MHz (Cooke, Germany), z-step motor, dual filter wheels, and a xenon 175-watt light source, all controlled by SlideBook 3.0 software (Intelligent Imaging Innovation, Denver, CO). Typically, 25-40 serial two-dimensional images were recorded at 100-to 200-nm intervals. A Z-stack of images obtained was deconvoluted using a modification of the constrained iteration method. Final arrangement of all images was performed using Adobe Photoshop.
Live Cell Microscopy and FRET Imaging-PAE or HEK293 cells transiently or stably co-expressing various YFP/CFP-tagged proteins were grown on glass coverslips. The coverslips were mounted in a microscope chamber and placed on a microscope stage. To visualize CFP and YFP, consecutive images were acquired through corresponding filter channels.
The method of sensitized FRET measurement has been described previously (19, 21) . We previously validated this technique by measuring FRET intensities in various control interaction pairs and by using the donor fluorescence recovery method (21) . Briefly, images were acquired sequentially through YFP, CFP, and FRET filter channels. Filter sets used were: YFP (excitation, 500/20 nm; emission, 535/30 nm), CFP (excitation, 436/10 nm; emission, 470/30 nm), and FRET (excitation, 436/10 nm; emission, 535/30 nm). An 86004BS dichroic mirror (Chroma, Inc.) was utilized. Binning 2 ϫ 2 modes and 100-to 250-ms integration times were used. The background images were subtracted from the raw images prior to carrying out FRET calculations. Corrected FRET (FRET C ) was calculated on a pixel-by-pixel basis for the entire image using Equation 1: C , CFP, and YFP fluorescence in the selected sub-region. In these calculations, the fluorescence intensity of CFP was underestimated because of donor fluorescence quenching due to FRET. The decrease in donor fluorescence was calculated from FRET C values using the conversion coefficient G (3.2 in all experiments) as described (22) and was found to be about 5-10% of CFP fluorescence intensities. Therefore, the underestimation did not significantly affect FRETN values. Because FRETN displays a non-linear dependence when donor or acceptor are in a significant molar excess over each other, FRETN values were calculated in the sub-regions of the cell in which the amount of the donor did not exceed the amount of the acceptor more than 2-fold and vice versa.
FRET C images are presented in pseudocolor mode. FRET C intensity is displayed stretched between the low and high renormalization values, according to a temperature-based lookup table with blue (cold) indicating low values and red (hot) indicating hot values. To eliminate the distracting data from regions outside of cells, the YFP channel was used as a saturation channel, and the FRET C images are displayed as YFP intensity-modulated images. In these images, data with YFP values greater than the high threshold of the saturation channel are displayed at full saturation, whereas data values below the low threshold are displayed with no saturation (i.e. black). All calculations were performed using the Channel Math and FRET modules of the SlideBook software.
RESULTS
Characterization of CFP-DAT and YFP-DAT-To visualize
DAT in living cells, fusion proteins of full-length DAT with YFP or CFP were generated, in which YFP or CFP was fused to the amino terminus of DAT (Fig. 1A) . Previous studies reported that the fusion of GFP or YFP to the amino terminus of DAT did not affect functional properties of the transporter (3, 23 (Fig. 1B) and were similar to values measured in our previous work with DAT expressed in Xenopus oocytes (24) .
The plasma membrane expression of DAT fusion proteins in PAE cells was confirmed by surface biotinylation assays using a membrane-impermeable derivative of biotin. Biotinylated un- tagged DAT and YFP-DAT migrated on SDS-PAGE as smeared bands of ϳ73-75 kDa and 103-105 kDa (the difference corresponds to ϳ26 kDa of YFP), respectively (Fig. 1C) . Minor biotinylated bands of ϳ180 -190 kDa for DAT and ϳ250 kDa for YFP-DAT were also detected. These forms may represent SDSresistant dimers of DAT and YFP-DAT, correspondingly. Several species of DAT and YFP-DAT were also detected in the supernatants from the NeutrAvidin affinity column. The nonbiotinylated forms, which migrated similar to the biotinylated forms, are likely to correspond to surface-exposed DAT (especially, in the case of YFP-DAT) that were not biotinylated due to the limited efficiency of biotinylation or internalized, endosomal DAT. Other forms with molecular weights different from the surface forms probably represent monomeric and dimeric species of DAT and YFP-DAT located intracellularly. A 75-to 80-kDa band of YFP-DAT (IC-1) recognized by antibodies to DAT (Fig. 1C) and GFP (data not shown) represents nonglycosylated YFP-DAT. The corresponding form of DAT (50 kDa) was poorly detected because of the overlap with IgG, but was clearly detectable in cell lysates (data not shown). A 180-to 190-kDa form (IC-2) may correspond to SDS-resistant dimers of IC-1 (Fig. 1C) .
That YFP-and CFP-DAT were efficiently transported along the biosynthetic pathway to the cell surface was also demonstrated by fluorescence microscopy. Fig. 2 shows that CFP-DAT and YFP-DAT co-expressed in PAE cells were mainly localized in the plasma membrane, often concentrating in ruffle-and phylopodia-like structures (Fig. 2) . In addition, a pool of fluo- rescent DAT could be also seen in the perinuclear and Golgi area of many cells. These transporters probably represent newly synthesized YFP/CFP-DAT located in the ER and Golgi complex.
FRET between CFP-DAT and YFP-DAT-DA uptake and cell surface biotinylation experiments validated the use of YFP-DAT and CFP-DAT expressed in PAE cells to examine the oligomeric state of these proteins in various cellular compartments. In previous studies we described a three-filter method of FRET microscopic analysis in living cells (19) . This method allows rapid measurement of sensitized FRET signals with high spatial resolution. Fig. 2A shows that positive CFP 3 YFP FRET C signals were detected in the diffuse fluorescence areas and phylopodia/ruffle structures of the plasma membrane when YFP-DAT and CFP-DAT were co-expressed in PAE cells. These data suggest that the amino termini of the two proteins are in close proximity to each other and that DAT forms dimers or higher oligomers at the cell surface.
As a control for FRET analysis of the CFP/YFP-DAT pair, we measured FRET signals in cells co-expressing YFP-DAT with an unrelated integral membrane protein, the receptor for epidermal growth factor (EGFR) tagged with CFP (EGFR-CFP). Co-expressed YFP-DAT and EGFR-CFP were highly co-localized in the plasma membrane (Fig. 2B) . However, no FRET C signals were detected in these cells, suggesting that the proteins did not form complexes.
Because the efficiency of energy transfer depends on the amount of donor and acceptor capable of interaction, FRET C values were divided by the product of YFP and CFP intensities on a pixel-by-pixel basis to obtain normalized FRET C (FRETN) values for various regions of the cell (see "Experimental Procedures"). FRETN values correlate with the equilibrium binding constant for the measured interaction and may, therefore, serve as a measure of the relative affinity of interaction (22) . FRETN values in cells expressing CFP-DAT/YFP-DAT were similar in the diffuse fluorescence areas and ruffle/phylopodia structures of the plasma membrane (Table I) . These values were substantially higher than in control cells expressing two co-localized but non-interacting proteins, EGFR-CFP and YFP-DAT (Table I) .
DAT has been shown to be capable of rapid endocytosis when heterologously expressed (3, 5, 6, 25) . To test whether DAT remains oligomerized during endocytic trafficking, the endocytosis of CFP-and YFP-DAT in PAE cells was induced by PMA. Exposure to PMA at 37°C for 5-30 min (1 M) caused accumulation of YFP-and CFP-DAT in vesicular structures in the perinuclear area in most of the cells, and this occurred concomitantly with a decrease in the plasma membrane fluorescence (Fig. 2) . Down-regulation of DAT has also shown to be triggered by amphetamine in HEK293 cells, although the endosomal localization of DAT in amphetamine-treated cells was not confirmed (6) . Using fluorescent DAT proteins we show here that YFP-and CFP-DAT accumulated in vesicular organelles after 2-h treatment of PAE cells at 37°C with 4 M amphetamine ( Fig. 2A) . In contrast to PMA-treated cells, visible accumulation of DAT in vesicular organelles was observed in a limited fraction of the amphetamine-treated cell population, and the extent of endosomal accumulation of DATs was smaller than in cells treated with PMA. Importantly, positive FRET C signals were detected in vesicular organelles containing YFP-and CFP-DAT in cells treated with either PMA or amphetamine ( Fig. 2A) . FRETN values varied significantly in different cells but were consistently higher in endosomes (see Table I ).
Phorbol esters are known to cause transient down-regulation and endosomal accumulation of EGFR (26) . Interestingly, PMA treatment of PAE cells co-expressing YFP-DAT and EGFR-CFP resulted in translocation of both cargoes into the same vesicular organelles (Fig. 2B) . As in the case of untreated cells, no FRET C signals between DAT-CFP and EGFR-YFP were detected in PMA-treated cells, suggesting that the proteins did not form complexes (Table I) .
Having shown FRET between co-expressed CFP-and YFP-DAT in endothelial cells, we examined whether similar oligomerization can be observed in dopaminergic cells. To this (20) . These cells begin to express tyrosine hydroxylase and differentiate under conditions of growth in the presence of dibutyryl cAMP (20) . Oligomerization of CFP/YFP-DAT was also observed in 1RB 3 AN 27 cells expressing CFP-DAT and YFP-DAT (Fig. 3) . CFP-and YFP-DAT displayed localization similar to that observed in PAE cells. FRET C signals were readily detectable at the cell surface in control cells, in endosomes in cells treated with PMA ( Fig. 3 and Table I ), and in the ER (data not shown).
Accumulation of CFP-DAT in Early Endosomes and Late Recycling Compartment in Cells
Treated with PMA and Amphetamine-To confirm that vesicular structures containing DAT in cells treated with PMA or amphetamine represent endosomal compartments, the localization of DAT was compared with that of endosomal markers. PAE cells stably expressing CFP-DAT (PAE/CFP-DAT) were transiently transfected with YFP-fused Rab5a (YFP-Rab5), a resident protein of early endosomes (27) or with YFP fusion of Rab11a (YFPRab11), a marker of early and late recycling endosomes (27, 28) . As shown in Fig. 4A , a number of DAT-CFP containing structures also contained YFP-Rab5 in cells treated with PMA or amphetamine, whereas there was very minimal, if any, localization of CFP-DAT in Rab5-positive endosomes in untreated cells. The pattern of distribution of two proteins within the endosomes was not, however, identical. High resolution images of living cells showed that CFP-DAT was typically distributed in the entire endosomal membrane and, possibly, inside the endosome. In contrast, YFP-Rab5 was often concentrated in one or several poles of the endosome, in so-called "Rab5 domains" (29) .
DAT was also well co-localized with another endosomal protein, Hrs (Fig. 4B ). This protein is involved in targeting of ubiquitylated cargo to the internal membranes of multivesicular bodies and lysosomal degradation pathway (30) . Hrs overexpression results in the blockade of endosomal trafficking, recruitment of clathrin to endosomes, and enlargement of endosomes (31) . Interestingly, however, DAT was mainly excluded from the Hrs-containing microdomains/coats within individual endosomes (Fig. 4B) , suggesting that the endosomal sorting of DAT is not mediated by the Hrs pathway.
YFP-Rab11 was mainly localized in tubular-vesicular and vesicular compartments in the Golgi area and cell periphery (Fig. 5) . As in the case of Rab5, a pool of CFP-DAT was colocalized with YFP-Rab11 in endosomes upon treatment with PMA or amphetamine. A small amount of CFP-DAT was seen co-localized with Rab11 in untreated cells, presumably as the result of constitutive internalization and recycling of CFP-DAT. These data demonstrate in living cells that DAT is internalized in response to PMA and amphetamine treatment into various types endosomal compartments that are involved in major sorting and recycling pathways.
Confocal microscopy was used to confirm the accumulation of DAT in early endosomes using an endogenous marker of these compartments. To this end, CFP-DAT localization was compared with localization of the early endosomal marker EEA.1 in fixed cells using image reconstitution by deconvolution of three-dimensional images (Fig. 6) . The optical sectioning revealed significant co-localization of CFP-DAT and EEA.1 in endosomes (Fig. 5) . Together, Figs. 4 -6 demonstrate the PMAor amphetamine-induced endocytosis of tagged DAT into earlyrecycling endosomal compartments, in which, according to FRET analysis, DAT molecules are oligomerized (Figs. 2-3) . residues) was deleted and replaced by YFP. PAE cells constitutively expressing DAT or YFP-⌬N-DAT alone were used as controls. YFP-⌬N-DAT was efficiently transported to the surface in PAE cells under all expression conditions based on surface biotinylation (Fig. 7A ) and fluorescence imaging experiments (Fig. 7B) . A similar, but untagged, DAT mutant was retained in the ER (17) . It is possible that the attachment of YFP to the truncated DAT in our experiments had a stabilizing effect on the transporter molecule, thus allowing proper folding of YFP-⌬N-DAT in the ER and effective ER export. Transient co-expression of YFP-⌬N-DAT with CFP-DAT in PAE cells resulted in co-localization of the two proteins in the plasma membrane and positive FRET C signals (Fig. 7B) , similar to what was observed with wild-type CFP-and YFP-DAT proteins (Fig. 2) . Despite expression at the cell surface, however, no [ 3 H]DA uptake by YFP-⌬N-DAT was detected (data not shown). Interestingly, a DAT mutant, in which the 59 amino terminal residues of DAT were deleted, is delivered to the plasma membrane and displayed normal dopamine transport in Madin-Darby canine kidney cells (32) . This may suggest a critical role of residues 59 -65 in DAT transport activity. Alternatively, the discrepancies between trafficking and transport activities of amino-terminally truncated DAT mutants observed by Gu and co-workers (32), Torres and co-workers (17) , and in our experiments may be due to different cellular backgrounds.
Co-immunoprecipitation of Wild-type Untagged and Mutant YFP-tagged DAT-FRET
In co-immunoprecipitation experiments, YFP-⌬N-DAT was precipitated from the lysates of PAE cells stably co-expressing DAT and YFP-⌬N-DAT using a GFP antibody. The immunoprecipitates were probed with rat anti-DAT antibody that recognizes the full-length DAT but not the YFP-⌬N-DAT mutant. The wild-type DAT migrating on SDS-PAGE at the position corresponding to monomeric plasma membrane DAT (73-75 kDa, see also Fig. 1 ) was detected in GFP immunoprecipitates, indicative of YFP-⌬N-DAT/DAT association (Fig. 7C) . Other forms of DAT were not detected in significant amounts in immunoprecipitates and cell lysates in these experiments. Based on densitometric analysis of the intensity of chemiluminescence signals from DAT immunoreactivity in anti-GFP immunoprecipitates and lysates, ϳ20% of total cellular DAT was co-immunoprecipitated with YFP-⌬N-DAT. Together with FRET analysis, these data strongly support the existence of DAT in an oligomeric state.
Oligomerization of YFP-DAT and CFP-DAT in the Biosynthetic Compartments-To test whether newly synthesized DAT exists as an oligomer during its anterograde transport through the ER and Golgi, a mutant of DAT with impaired transport to the plasma membrane was constructed. In this mutant the last five amino acid residues of the carboxyl terminus that include a PDZ (PSD/Discs large/zona occludens-1) domain-binding sequence important for plasma membrane transport (7) were deleted (YFP-DAT-CЈ615). When transiently expressed in PAE or other cells for 1-2 days, this mutant was primarily localized in the tubular-vesicular network seen throughout the entire cell, often in the nuclear envelope membrane and concentrated in the Golgi area (Fig. 8) . This pattern of localization is typical 
FIG. 7. Interaction of amino-terminal deleted YFP-⌬N-DAT fusion protein with full-length DAT detected by FRET and coimmunoprecipitation.
A, PAE cells stably expressing YFP-⌬N-DAT were subjected to surface biotinylation as described in Fig. 1C . NeutrAvidin-conjugated beads (NeuAv) were resolved by SDS-PAGE, and DAT was detected by Western analysis using rat anti-DAT. The two lanes are duplicates. B, CFP-DAT and YFP-⌬N-DAT were transiently coexpressed in PAE cells, and FRET was measured as described in Fig. 2 . FRET C is presented as pseudocolor intensity-modulated images (FRET C /YFP). A.l.u.f.i, arbitury linear units of fluorescence intensity. Bar, 10 m. C, PAE cells stably expressing wild-type DAT and YFP-⌬N-DAT or co-expressing both DAT and YFP-⌬N-DAT were lysed, and YFP-⌬N-DAT was precipitated using anti-GFP antibody. Immunoprecipitates and aliquots of lysates (11% of the amount used for immunoprecipitation) were probed with antibodies to DAT or GFP. DAT-M and YFP-⌬N-DAT-M, monomeric forms of DAT and YFP-⌬N-DAT, respectively. Intracellular, presumably, immature forms of 75 kDa and ϳ180 -190 kDa of YFP-⌬N-DAT were not detected in significant amounts in these cells.
of the distribution of newly synthesized proteins in the ER, intermediate compartment, and Golgi complex (further referred as "ER localization"). A small pool of YFP-DAT-CЈ615 could be detected at the cell surface after 3 days of expression, in contrast to DAT mutants lacking 35 or 42 amino acid residues of the carboxyl terminus, which were not transported to the plasma membrane under any conditions (data not shown).
When YFP-DAT-CЈ615 was co-expressed with CFP-DAT, both proteins were co-localized in the ER in some cells. In other cells CFP-DAT displayed strong plasma membrane fluorescence, whereas YFP-DAT-CЈ615 was located in the ER. Analysis of the relative expression of the two transporters in individual cells revealed that in cells with a relatively high CFP/YFP ratio (for example, 3:1 in Fig. 8A) , most of the CFP-DAT reached the cell surface. In contrast, in cells expressing relatively higher levels of YFP-DAT-CЈ615 (for example, 1:1 CFP/ YFP ratio in Fig. 8A ), both wild-type and mutant DAT were retained in the ER. In the latter case, positive FRET C signals were detected, suggesting CFP-DAT/YFP-DAT-CЈ615 oligomerization in the ER (Fig. 8A and Table I ).
To control for the specificity of FRET signals in the ER, YFP-DAT-CЈ615 was co-expressed with EGFR-CFP for 16 -18 h. At this time after transfection, a large pool of EGFR-CFP was moving through the biosynthetic pathway and was highly co-localized with YFP-DAT-CЈ615 (Fig. 8B) . However, no positive FRET signal was detected (Fig. 8B) . The FRETN values of ER-localized YFP/CFP-DAT in PAE cells were on average lower than these values in other cellular compartments, although they were significantly higher than FRETN of the negative control, EGFR-CFP/YFP-DAT-CЈ615 (Table I ). The data presented in Fig. 8A suggest that the formation of heterooligomers between the wild-type DAT and the ER export-defective DAT mutant may interfere with the normal delivery of wild-type DAT to the cell surface.
To further substantiate this conclusion, the effect of overexpression of DAT-CЈ615 on plasma membrane expression of wild-type DAT was examined using a surface biotinylation assay. DAT expression levels were relatively low in PAE cells, particularly, when the two DAT fusion proteins were co-expressed. Therefore, for these biochemical experiments we used HEK293 cells, which allow high efficiency of DAT expression in a large fraction of the cell population. These cells have previously been well characterized as a DAT expression system (6). Transiently co-expressed CFP-DAT and YFP-DAT were located at the plasma membrane in many HEK293 cells (Fig. 9A) , although in cells with very high levels of expression, the two proteins were often retained in the ER. As observed in PAE cells, CFP-DAT was retained together with the traffic-defective mutant YFP-DAT-CЈ615 in the ER of HEK293T cells when the mutant was expressed at near equimolar or higher levels compared with CFP-DAT (Fig. 9A) .
Co-expression of YFP-DAT-CЈ615 with untagged DAT significantly and concentration-dependently reduced the amount of DAT detectable by surface biotinylation (Fig. 9B) . Only small amounts of a 105-kDa form of YFP-DAT-CЈ615 (corresponding to the monomeric plasma membrane form of YFP-DAT, see Fig.  1 ) was detected by blotting with anti-GFP in lysates (Fig. 9B,  right panel) and the biotinylated fraction (data not shown). The major forms of the mutant (75-80 kDa and 180 -190 kDa bands) were not accessible to surface biotinylation and were, therefore, located intracellularly (Fig. 9B) . These data are consistent with the imaging analysis demonstrating an impaired transport of YFP-DAT-CЈ615 to the cell surface. The dominantnegative effect of the ER export-deficient DAT mutant on surface expression of DAT further suggested that oligomerization of the newly synthesized DAT occurs in the ER and that proper DAT oligomerization is necessary for the efficient transport of DAT from the ER to the plasma membrane.
DISCUSSION
In this study we used fluorescence microscopy to visualize the compartmentalization and oligomerization state of DAT in living cells. We chose to use the PAE endothelial cells as the main expression system for YFP-or CFP-DAT. In addition to the usefulness of these cells for fluorescence microscopy studies (19) , we found that PAE cells were the best model in which to perform experiments with transiently expressed DAT fusion constructs. Unlike HEK293, COS-1, and HeLa cells, in which transient expressions resulted in the retention of DAT in the ER in a large fraction of the cell population, wild-type DAT was effectively delivered to the cell surface in PAE cells. Moreover, PAE/DAT cells responded with strong DAT endocytosis to PMA-and amphetamine exposure. Finally, PAE cells appear to have the tightest quality control for protein folding in the ER, presumably due to a high capacity for proteasomal degradation at the ER. This was evidenced by the observations that DAT mutants lacking large portions or an entire carboxyl terminus and incapable of effective ER export were usually expressed only at very low levels in PAE cells (data not shown).
Phorbol ester-induced endocytosis of DAT has been demonstrated previously in several heterologous-expression systems (3, 5) . Accordingly, exposure to 1 M PMA caused a dramatic accumulation of fluorescent DAT in endosomes of PAE cells, as well as in an immortalized dopaminergic cell line 1RB 3 AN 27 . These endosomes contained Rab5, EEA.1, and Hrs and can be classified as early and intermediate compartments. To a lesser extent, DAT was localized in the late recycling compartment identified by Rab11. Interestingly, however, DAT was mainly excluded from Rab5 and Hrs microdomains in endosomes. This observation suggests that DAT is not specifically recruited to the Hrs-dependent degradation pathway used mainly by ubiquitylated cargo (30) .
Moreover, using PAE/DAT cells we were able to demonstrate endocytosis of DAT induced by 4 M amphetamine into the same early/recycling endosomal compartments. This observation provides direct support for the hypothesis that DAT down-regulation observed upon similar exposure to amphetamine in HEK293 cells is the result of DAT internalization to endosomes (6) . In all of these studies, including our own, relatively long exposure times were used. However, evidence from experiments following in vivo exposure to methamphetamine and DA supports the relevance of substrate-induced down-regulation in brain (4, 33, 34) . Furthermore, protein kinase C inhibitors block substrate-induced DAT down-regulation in in vitro models, suggesting that protein kinase C-induced endocytosis is involved in the regulation mediated by substrates (4, 35, 36) .
The capability to visualize trafficking of functional YFP/ CFP-DAT in PAE cells prompted us to use FRET to analyze DAT oligomerization. Biochemical methods of detection of dimerization, such as immunoprecipitation and cross-linking, require cell disruption and cannot guarantee that dimers are not formed during cell lysis. In contrast, the FRET technique allows detection of dimerization in intact living cells. Modification of the three-filter method to measure sensitized FRET was previously employed in our studies of proteins involved in trafficking and signaling of EGFR (19) Table I have relatively high standard deviations, as have been observed in all previous studies using this technique (22, 37) . Furthermore, the biological significance of the differences among FRETN values obtained in different cellular compartments is uncertain. The ER in PAE cells tended to yield the lowest FRETN values, presumably due to low local concentrations of YFP-and CFP-DAT in this organelle in these cells. The highest FRETN values were obtained in endosomes, possibly because of the high local concentrations of DAT fusion proteins in these compartments. Overall, the results of the FRET analysis suggest that DAT is oligomerized constitutively and that it is unlikely that oligomerization is involved in the regulation of endocytic trafficking.
Dimerization or higher oligomerization may be, however, important for DAT trafficking from the ER to the plasma membrane. Figs. 8 and 9 show that overexpression of an ER exportdefective mutant has a dominant-negative effect on the plasma membrane transport of wild-type DAT. The same effects were convincingly documented in a report by Torres and co-workers (17) . These observations are consistent with the model whereby ER export-competent DAT molecules must oligomerize to traffic through the ER-Golgi system to the cell surface. The impor- . The DNA ratios of YFP-DAT-CЈ615 and DAT used for transfections are indicated. The total amount of DNA per dish was 1 g/ml. After 2 days of expression, two parallel dishes were used to determine the amount of plasma membrane DAT by surface biotinylation as described in Fig. 1C tance of oligomerization of GAT-1 for transport to the plasma membrane has been directly demonstrated by Scholze and co-workers (13) .
The mechanisms responsible for DAT-DAT intermolecular interactions have recently begun to be elucidated. It is likely that TM domains are responsible for oligomerization. For example, in our experiments deletion of the amino terminus of DAT did not prevent DAT-DAT oligomerization. The predicted leucine zipper motif in TM2 appears to be involved in the intermolecular interactions (17) , similar to what was demonstrated for GAT-1 oligomerization (13) . TM6 has also been proposed to be one of the interaction interfaces (16) . Studies of DAT molecular size using radiation inactivation predicted that DAT is a tetramer (14, 15) . The tetrameric state of SERT was also predicted based on co-immunoprecipitation experiments (11) . However, our FRET microscopic analysis does not provide a reliable way to distinguish tetramerization from dimerization.
Although live-cell FRET analysis requires expression of transporters in heterologous systems, DAT oligomerization has been demonstrated in an immortalized dopaminergic cell line (Fig. 3) and rat striatum by both cross-linking and radiation inactivation techniques (14, 16) , suggesting that this property of the DAT molecule may be important for its function in dopaminergic neurons. The exact functional role of DAT oligomerization in the regulation of DA uptake remains to be elucidated. However, expression of SERT concatenations consisting of four SERT molecules resulted in chimeric proteins with increased affinities for serotonin uptake (9) . Oligomerization of SERT has also been suggested to be important for efficient serotonin transport (11) . Because TM domains are critical for both proper folding and oligomerization of DAT, mutations in TM domains can affect the transport capacity of DAT at the plasma membrane indirectly through the poor delivery of the newly synthesized transporter to the plasma membrane, as well as directly. Therefore, careful analysis of subcellular localization of TM mutants of DAT will be necessary to elucidate the role of oligomerization in the transport function of DAT.
